Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Rafael Holdings
RFL
$104M
| $1.26M | ﹤0.01% |
24,941
+30
| +0.1% | +$1.31K |
|
2852
Team
TISI
$79.8M
| $1.25M | ﹤0.01% |
18,727
-1,957
| -9% | -$178K |
|
|
OSH
2853
DELISTED
Oak Street Health, Inc.
OSH
| $1.25M | ﹤0.01% |
21,415
+6,693
| +45% | +$398K |
|
|
ORC
2854
Orchid Island Capital
ORC
$1.32B
| $1.25M | ﹤0.01% |
48,206
+5,744
| +14% | +$160K |
|
2855
Avita Medical
RCEL
$138M
| $1.25M | ﹤0.01% |
+60,655
| New | +$1.2M |
|
2856
Utah Medical Products
UTMD
$222M
| $1.24M | ﹤0.01% |
14,558
-2,182
| -13% | -$189K |
|
2857
Invesco Dividend Achievers ETF
PFM
$792M
| $1.24M | ﹤0.01% |
34,117
-5,476
| -14% | -$197K |
|
2858
Mistras Group
MG
$483M
| $1.24M | ﹤0.01% |
125,715
+5,118
| +4% | +$55.2K |
|
2859
Stereotaxis
STXS
$133M
| $1.23M | ﹤0.01% |
127,923
+12,489
| +11% | +$98.6K |
|
|
VWTR
2860
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $1.23M | ﹤0.01% |
92,545
-38,255
| -29% | -$394K |
|
2861
Disc Medicine
IRON
$3.03B
| $1.21M | ﹤0.01% |
6,237
+1,442
| +30% | +$474K |
|
2862
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
| $1.21M | ﹤0.01% |
10,442
-1,437
| -12% | -$166K |
|
2863
Atlassian
TEAM
$24.9B
| $1.21M | ﹤0.01% |
4,696
+210
| +5% | +$49.2K |
|
|
SQZ
2864
DELISTED
SQZ Biotechnologies Company
SQZ
| $1.21M | ﹤0.01% |
83,446
+37,832
| +83% | +$494K |
|
2865
HBT Financial
HBT
$1.3B
| $1.2M | ﹤0.01% |
68,979
+1,231
| +2% | +$21.9K |
|
2866
Bolt Biotherapeutics
BOLT
$7.47M
| $1.19M | ﹤0.01% |
3,844
-200
| -5% | -$81.2K |
|
|
AKTS
2867
DELISTED
Akoustis Technologies Inc
AKTS
| $1.19M | ﹤0.01% |
110,905
+20,637
| +23% | +$218K |
|
2868
Dream Finders Homes
DFH
$1.22B
| $1.19M | ﹤0.01% |
48,556
+1,231
| +3% | +$31.8K |
|
2869
Metropolitan Bank Holding Corp
MCB
$1.15B
| $1.18M | ﹤0.01% |
19,535
+1,360
| +7% | +$82.8K |
|
|
ETNB
2870
DELISTED
89bio
ETNB
| $1.18M | ﹤0.01% |
62,846
+3,466
| +6% | +$77.4K |
|
2871
Old Second Bancorp
OSBC
$1.29B
| $1.17M | ﹤0.01% |
94,321
+22,069
| +31% | +$295K |
|
2872
Harrow
HROW
$1.45B
| $1.16M | ﹤0.01% |
124,962
+69,296
| +124% | +$591K |
|
2873
PAVmed
PAVM
$36.2M
| $1.16M | ﹤0.01% |
403
+43
| +12% | +$102K |
|
|
NAGE
2874
Niagen Bioscience
NAGE
$264M
| $1.16M | ﹤0.01% |
117,450
+10,986
| +10% | +$95.8K |
|
|
MMAT
2875
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $1.16M | ﹤0.01% |
1,547
+1,304
| +537% | +$728K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.